Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly

GA Wright, GJ Klein, LJ Gula - Current Opinion in Cardiology, 2013 - journals.lww.com
Ethical and legal perspective of implantable cardioverter de... : Current Opinion in
Cardiology Ethical and legal perspective of implantable cardioverter defibrillator …

Effective communication and ethical consent in decisions related to ICDs

AM Clark, T Jaarsma, P Strachan… - Nature Reviews …, 2011 - nature.com
This Review examines recommendations and principles that promote good decision-making
with regard to the insertion, deactivation, and potential malfunction of implantable …

Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the …

C Kolb, M Sturmer, P Sick, S Reif, JM Davy, G Molon… - JACC: Heart Failure, 2014 - jacc.org
Abstract Objectives: The OPTION (Optimal Anti-Tachycardia Therapy in Implantable
Cardioverter-Defibrillator Patients Without Pacing Indications) trial sought to compare long …

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators

J Vijgen, G Botto, J Camm, CJ Hoijer, W Jung… - Europace, 2009 - academic.oup.com
Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden
incapacitation that might cause harm to others while driving a car. Driving restrictions vary …

Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients–Potential markers of ventricular arrhythmia

V Sawhney, NG Campbell, SW Brouilette… - International journal of …, 2016 - Elsevier
Abstract Background Implantable cardioverter defibrillators (ICDs) reduce mortality in
patients with ischaemic cardiomyopathy at high risk of ventricular arrhythmias (VA) …

[HTML][HTML] Sensing and detection functions in implantable cardioverter defibrillators: the good, the bad and the ugly

A Kossaify - Acta Cardiologica Sinica, 2020 - ncbi.nlm.nih.gov
Implantable cardioverter defibrillators are small devices that have been proven to be
beneficial by preventing sudden cardiac death, whether in primary or secondary prevention …

Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study

C Perings, W Rudolf Bauer, HJ Bondke, C Mewis… - Europace, 2011 - academic.oup.com
Abstract Aims Intracardiac electrograms (IEGMs) recorded by implantable cardioverter-
defibrillators (ICDs) are essential for arrhythmia diagnosis and ICD therapy assessment …

Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable …

J Vijgen, G Botto, J Camm, CJ Hoijer… - European journal of …, 2010 - academic.oup.com
Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden
incapacitation that might cause harm to others while driving a car. Driving restrictions vary …

Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator

EYN Cho, R von Känel, B Marten-Mittag, J Ronel… - Heart, 2012 - heart.bmj.com
Objective The implantable cardioverter defibrillator (ICD) is the gold standard therapy to
prevent life-threatening arrhythmias. Phobic anxiety predicts ventricular arrhythmia in …

Antiarrhythmic properties of ranolazine–from bench to bedside

S Tzeis, G Andrikopoulos - Expert opinion on investigational drugs, 2012 - Taylor & Francis
Introduction: Pharmacological management of cardiac arrhythmias is limited by the reduced
availability of safe and effective antiarrhythmic agents. Areas covered: Ranolazine is an …